Back to News
Market Impact: 0.2
Transmedics Names Fernando Araujo CFO, Reiterates FY26 Outlook
Source: Nasdaq
Management & GovernanceCorporate Guidance & OutlookHealthcare & Biotech
TransMedics Group appointed Fernando Araujo as CFO effective September 21 and reiterated its full-year 2026 revenue guidance. The confirmation of outlook signals operational continuity, while the executive appointment is unlikely to materially affect shares absent further financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
TMDX0.20
More News
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Nvidia's role as AI financier faces first big test as neoclouds take market hit
- IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
- ‘There’s nothing temporary about a temporary store’: How Spirit Halloween’s CEO took it from 130 stores to 1,550—and swallowed your mall’s Hot Topic
- Thousands of Israelis rally against Netanyahu gov’t days before election
- Rick Lazio: We’ve lost an auto race before, China’s EV climb should worry us